Company news
Oruka Therapeutics, Inc. news in 2021
Oruka Therapeutics, Inc.'s news releases, calls and decks from 2021, newest first.
ARCA biopharma Announces Completion of Enrollment in Phase 2b ASPEN-COVID-19 Clinical Trial Evaluating rNAPc2 as a Potential Treatment for Patients Hospitalized with COVID-19
December 1, 2021
ARCA biopharma to Present at the Q4 Virtual Investor Summit on November 17th
November 8, 2021
ARCA biopharma Announces Third Quarter 2021 Financial Results and Provides Corporate Update
November 1, 2021
ARCA biopharma Announces Enrollment of First International Patient in Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19
September 15, 2021
ARCA biopharma to Present at the Q3 Virtual Investor Summit on August 18th
August 15, 2021
ARCA biopharma Announces Submission of PCT Patent Application for the Treatment of Coronavirus Infection and Associated Coagulopathy with rNAPc2
August 8, 2021
ARCA biopharma Announces Second Quarter 2021 Financial Results and Provides Corporate Update
August 3, 2021
Gencaro Atrial Fibrillation Phase 2B Results Selected for Publication in Circulation: Arrhythmia and Electrophysiology
July 27, 2021
ARCA biopharma Announces rNAPc2 COVID-19 Patent Assignment Agreement
July 6, 2021
ARCA biopharma Announces First Quarter 2021 Financial Results and Provides Corporate Update
May 10, 2021
ARCA biopharma Announces C. Jeff Dekker to be Appointed Chief Financial Officer
May 2, 2021
ARCA biopharma Announces 2020 Financial Results and Provides Corporate Update
March 17, 2021